Eczema and dry skin – observational analysis of patients prescription patterns and healthcare utilization: a retrospective observational cohort study

Johnson & Johnson Ltd0 个研究点目标入组 1,570 人开始时间: 2017年7月19日最近更新: 2018年11月19日

适应症

试验速览

•1. Patients with dry skin and/or eczema in 2008 and 2012
•2. Exposed cohort: patients with at least 2 distinct emollient prescriptions within 6 months of index
•3. Control cohort: patients with 2 healthcare exposures (visits or prescriptions) for dry skin and/or eczema in 6 months but no emollient prescriptions at any time
•4. Continuous = 12 months of medical history prior to diagnosis (washout period) and = 24 months post dry skin and/or eczema diagnosis. The index date will be the date of dry skin and/or eczema diagnosis in those patients with at least 12 months washout period (i.e., first diagnosis in at least 12 months – this constitutes the clean” period)

•1. Patients with concurrent skin diseases that are typically treated with topical corticosteroids (TCS) such as bullous pemphigoid, lupus, lichen planus, granuloma annulare, lichen sclerosis, alopecia areata and vitiligo
•2. Patients with low-quality records or non-continuous data coverage
•3. A diagnosis of dry skin-eczema during the washout period (12 months period prior to index diagnosis)

发起方